News

Dana Boucher found relief with LUTATHERA, a targeted radioactive therapy specifically for neuroendocrine tumors (NETs) found in the gut or pancreas.

Health care leaders and first responders gathered at Saint Luke's South Hospital to discuss ongoing efforts in the fight against fentanyl with U.S. Rep. Sharice Davids.

In 2023, an emergency colonoscopy led to Michael's diagnosis of stage 3 cancer. Because of his experience, Michael Kathrens, 70, advocates for proactive health screenings and being an advocate for your own health.

Nellie Jo Gaston received a lifesaving surgery after an abnormal result from an at-home colon cancer screening test. After treatment at Saint Luke’s, she is cancer-free.

Weeks shy of the bar exam, the trajectory of Jackson’s life was rocked off course when he was diagnosed with stage 3 colon cancer. The 26-year-old’s diagnosis was an obstacle that he refused to let topple him.

Jackson Auer was two days away from his 26th birthday when he was diagnosed with stage 3 colon cancer. 10 months later, Jackson is now cancer-free, newly engaged, and hoping to raise awareness of the disease.

According to the American Cancer Society, those under the age of 50 are experiencing an increase in colorectal cancer diagnoses, but also an increase in colorectal cancer deaths.

Dr. Tim Pluard talks about an exciting expansion that will make cancer care more accessible to Kansas City’s growing Northland community.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.

Dr. Tim Pluard, medical director of Saint Luke’s Koontz Center for Advanced Breast Cancer and of Saint Luke’s Cancer Institute, talks about innovative treatment options for breast cancer and clinical trials offered at Saint Luke’s.